159 related articles for article (PubMed ID: 23729280)
1. Developing a system to track meaningful outcome measures in head and neck cancer treatment.
Walters RS; Albright HW; Weber RS; Feeley TW; Hanna EY; Cantor SB; Lewis CM; Burke TW
Head Neck; 2014 Feb; 36(2):226-30. PubMed ID: 23729280
[TBL] [Abstract][Full Text] [Related]
2. Processes and outcomes of head and neck cancer patients from geographically disparate regions of the UK. A comparison of Scottish and English cohorts.
MacKenzie K; Savage SA; Birchall MA
Eur J Surg Oncol; 2009 Oct; 35(10):1113-8. PubMed ID: 19406610
[TBL] [Abstract][Full Text] [Related]
3. Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer.
Givens DJ; Karnell LH; Gupta AK; Clamon GH; Pagedar NA; Chang KE; Van Daele DJ; Funk GF
Arch Otolaryngol Head Neck Surg; 2009 Dec; 135(12):1209-17. PubMed ID: 20026818
[TBL] [Abstract][Full Text] [Related]
4. Trends in epidemiology and treatment and outcome for head and neck cancer: a population-based long-term analysis from 1996 to 2011 of the Thuringian cancer registry.
Guntinas-Lichius O; Wendt TG; Kornetzky N; Buentzel J; Esser D; Böger D; Müller A; Schultze-Mosgau S; Schlattmann P; Schmalenberg H
Oral Oncol; 2014 Dec; 50(12):1157-64. PubMed ID: 25459063
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting swallow outcome following treatment for advanced oral and oropharyngeal malignancies.
Kalavrezos N; Cotrufo S; Govender R; Rogers P; Pirgousis P; Balasundram S; Lalabekyan B; Liew C
Head Neck; 2014 Jan; 36(1):47-54. PubMed ID: 23559533
[TBL] [Abstract][Full Text] [Related]
6. Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy.
Chen AM; Daly ME; Farwell DG; Vazquez E; Courquin J; Lau DH; Purdy JA
JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):129-33. PubMed ID: 24337483
[TBL] [Abstract][Full Text] [Related]
7. Perception of head and neck cancer quality of life within the medical world: a multicultural study.
Demez PH; Moreau PR
Head Neck; 2009 Aug; 31(8):1056-67. PubMed ID: 19340871
[TBL] [Abstract][Full Text] [Related]
8. Multiple head and neck malignancies.
Odette J; Szymanowski RT; Nichols RD
Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1977; 84(5):ORL805-13. PubMed ID: 919150
[TBL] [Abstract][Full Text] [Related]
9. Life after total laryngectomy: a measure of long-term survival, function, and quality of life.
Woodard TD; Oplatek A; Petruzzelli GJ
Arch Otolaryngol Head Neck Surg; 2007 Jun; 133(6):526-32. PubMed ID: 17576901
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for local-regional recurrence following preoperative radiation therapy and surgery for head and neck cancer (stage II-IVB).
Shikama N; Sasaki S; Nishikawa A; Koiwai K; Yoshino F; Hirase Y; Kawakami R; Kadoya M; Oguchi M
Radiology; 2003 Sep; 228(3):789-94. PubMed ID: 12954897
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
[TBL] [Abstract][Full Text] [Related]
12. Supraglottic laryngeal cancer: analysis of treatment results.
Sessions DG; Lenox J; Spector GJ
Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of laser thermal therapy for recurrent head and neck cancer.
Sercarz JA; Bublik M; Joo J; Paiva PB; Areco KN; Brandalise MH; Loh C; Masterman-Smith M; Paiva MB
Otolaryngol Head Neck Surg; 2010 Mar; 142(3):344-50. PubMed ID: 20172378
[TBL] [Abstract][Full Text] [Related]
14. Long-term quality-of-life evaluation after head and neck cancer treatment in a developing country.
Vartanian JG; Carvalho AL; Yueh B; Priante AV; de Melo RL; Correia LM; Köhler HF; Toyota J; Kowalski IS; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2004 Oct; 130(10):1209-13. PubMed ID: 15492171
[TBL] [Abstract][Full Text] [Related]
15. Integration of prospective quality of life and nutritional assessment as routine components of multidisciplinary care of patients with head and neck cancer.
Oates J; Clark JR; Read J; Reeves N; Gao K; O'Brien CJ
ANZ J Surg; 2008; 78(1-2):34-41. PubMed ID: 18199203
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of head and neck cancer patients referred to an oral and maxillofacial surgeon in the United States for management.
Holmes JD; Martin RA; Gutta R
J Oral Maxillofac Surg; 2010 Mar; 68(3):555-61. PubMed ID: 20171475
[TBL] [Abstract][Full Text] [Related]
17. Extent of pathologic extracapsular extension and outcomes in patients with nonoropharyngeal head and neck cancer treated with initial surgical resection.
Prabhu RS; Hanasoge S; Magliocca KR; Moeller BJ; Milas ZL; Hall WA; El-Deiry M; Wadsworth JT; Higgins KA; Beitler JJ
Cancer; 2014 May; 120(10):1499-506. PubMed ID: 24510454
[TBL] [Abstract][Full Text] [Related]
18. A population-based study of therapy and survival for patients with head and neck cancer treated in the community.
Dansky Ullmann C; Harlan LC; Shavers VL; Stevens JL
Cancer; 2012 Sep; 118(18):4452-61. PubMed ID: 22252676
[TBL] [Abstract][Full Text] [Related]
19. Relative importance of diagnostic delays in different head and neck cancers.
Teppo H; Alho OP
Clin Otolaryngol; 2008 Aug; 33(4):325-30. PubMed ID: 18983341
[TBL] [Abstract][Full Text] [Related]
20. Epidemiologic evidence of superior outcomes for extramedullary plasmacytoma of the head and neck.
Gerry D; Lentsch EJ
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):974-81. PubMed ID: 23482476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
